What sector does GENOVIS AB SE-40 (5GV) operate in?
GENOVIS AB SE-40 belongs to the Healthcare sector and operates in the Biotechnology industry.
What is GENOVIS AB SE-40 (5GV) current stock price?
As of the latest data, GENOVIS AB SE-40 stock price is €2.58, with a previous close of €2.50. GENOVIS AB SE-40 gained €0.08 in the last trading session, representing a 3% increase.
What is GENOVIS AB SE-40 (5GV) current market capitalization?
GENOVIS AB SE-40 market cap is approximately 168.57 million.
What is GENOVIS AB SE-40 (5GV) Earnings Per Share (EPS)?
The trailing EPS is €0.03.
What is GENOVIS AB SE-40 (5GV) Price-to-Earnings (P/E) ratio?
GENOVIS AB SE-40 current P/E ratio is 85.83.
Does GENOVIS AB SE-40 (5GV) pay dividends?
No. GENOVIS AB SE-40 does not pay a dividend.
When is GENOVIS AB SE-40 (5GV) next earnings report?
GENOVIS AB SE-40 is expected to release its next earnings report on June 30, 2025.
What is GENOVIS AB SE-40 (5GV) beta (volatility) score?
GENOVIS AB SE-40 has a beta of 1.912, suggesting it is more volatile than the market.